Web Results

Bortezomib

en.wikipedia.org/wiki/Bortezomib

Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. Proteasomes are cellular complexes that break down proteins. In some cancers ...

VELCADE® (bortezomib) Official Website

www.velcade.com/

The Official Website for VELCADE® (bortezomib). ... VELCADE (bortezomib) is approved for the treatment of people with multiple myeloma (a cancer of the ...

Bortezomib: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/bortezomib.html

Easy to read patient leaflet for bortezomib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Velcade (Bortezomib): Side Effects, Interactions, Warning, Dosage ...

www.rxlist.com/velcade-drug.htm

Oct 9, 2015 ... VELCADE® for Injection contains bortezomib which is an antineoplastic agent. Bortezomib is a modified dipeptidyl boronic acid. The chemical ...

Bortezomib - Drug Information - Chemocare

chemocare.com/chemotherapy/drug-info/bortezomib.aspx

(bore TEZ oh mib). Trade name: Velcade<sup>®</sup>. Chemocare.com uses generic names in all descriptions of drugs. Velcade is the trade name for Bortezomib. In some ...

Buy Bortezomib (PS-341) | Proteasome inhibitor | Price | IC50 ...

www.selleckchem.com/products/Bortezomib.html

Bortezomib (PS-341). Catalog No.S1013. 20 Reviews. Bortezomib (PS-341) is a potent 20S proteasome inhibitor with Ki of 0.6 nM in a cell-free assay.

Bortezomib (Velcade) | Cancer Research UK

www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/cancer-drugs/bortezomib

Feb 12, 2014 ... The biological therapy drug bortezomib (Velcade) is a treatment for myeloma. The possible side effects include feeling or being sick; tiredness; ...

DrugBank: Bortezomib

www.drugbank.ca/drugs/DB00188

Jun 13, 2005 ... The boron atom within bortezomib catalytically binds the active site of the 26S proteasome with high affinity and specificity, thereby resulting in ...

Bortezomib (Velcade®) - Cancer Information - Macmillan Cancer ...

www.macmillan.org.uk/cancerinformation/cancertreatment/treatmenttypes/biologicaltherapies/cancergrowthinhibitors/bortezomib.aspx

Find out about bortezomib, which is commonly known as Velcade®

(bortezomib) Information - FDA

www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm106494.htm

Jul 9, 2015 ... The Food and Drug Administration has approved Velcade to treat a type of cancer called multiple myeloma. Velcade should only be used in ...

More Info

Bortezomib: MedlinePlus Drug Information

medlineplus.gov

Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with at least one other ...

Definition of bortezomib - NCI Drug Dictionary - National Cancer ...

www.cancer.gov

Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that degrades ubiquinated proteins. By blocking the targeted proteolysis normally ...

Bortezomib as the First Proteasome Inhibitor Anticancer Drug - NCBI

www.ncbi.nlm.nih.gov

Bortezomib (Velcade, Millennium Pharmaceuticals, Inc., Cambridge, MA, and Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, NJ) ...